Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.Starbucks China responded to the newly created position of Chief Growth Officer: to promote the sustainable development of Starbucks brand in China. Recently, some media reported that the management of Starbucks China continued to adjust and hired CGO to manage the growth from digital marketing companies. In response to the above information, Sina Technology verified Starbucks, and the official response said: China is Starbucks' largest international market and an important engine for the company's future growth. In November, Starbucks China established the Chief Growth Officer (CGO) organization and appointed Tony Yang as the company's Chief Growth Officer (CGO). The establishment of CGO organization will continue to strengthen Starbucks' coffee leadership, accelerate the product innovation with coffee as the core, better refresh customers' Starbucks experience at various contacts through integrated marketing strategies, and promote the sustainable development of Starbucks brand in China. At present, Starbucks has more than 7,600 stores in China, reaching a new development milestone covering 1,000 county-level markets. (Sina Technology)Indian Rupee fell below 84.8575 against the US dollar, hitting an all-time low.
Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.Sony group's share price hit a record high in intraday trading.Sinotrans has set up a new company, including land international cargo transportation agency business. The enterprise search APP shows that recently, Sinotrans Logistics (Alashankou) Co., Ltd. was established with Chen Xin as its legal representative and registered capital of 10 million yuan. Its business scope includes: domestic container cargo transportation agency; International freight forwarder; Land international freight forwarding agent; Import and export agents, etc. Enterprise survey shows that the company is indirectly wholly-owned by Sinotrans.
The "moderately loose" monetary policy boosted the confidence of all parties. A50ETF Huabao (159596) attracted 17.02 million yuan of gold yesterday. On December 11, the Shanghai Composite Index fluctuated within a narrow range in the morning, and A50ETF Huabao (159596) fell slightly by 0.18% with a turnover of 84.21 million yuan. In terms of constituent stocks, the top ten awkward stocks are mixed. On the upside, Midea Group led the gains, followed by Zijin Mining and Changjiang Power. On the downside, Hengrui Pharma led the decline. In terms of capital flow, A50ETF Huabao (159596) received a net inflow of 17.02 million yuan yesterday. China Post Securities said that the the Political Bureau of the Communist Party of China (CPC) Central Committee meeting continued to actively set the tone, and the policy turned loose, and expanding domestic demand in all directions became the current policy direction. This meeting made it clear that "strengthening unconventional countercyclical adjustment" and the fiscal policy adjustment was "more active", which basically met market expectations; The monetary policy is set to be "moderately loose", and the tone is adjusted again after 14 years. Next year, it is expected to be wide in currency and credit.Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.President of Japan Life Insurance: I don't think we are behind our competitors in overseas acquisitions, but we are concerned about different countries.